Cited by 146Blood Pressure and Hypertension StudiesCardiovascular Health and Disease PreventionHormonal Regulation and Hypertension

Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality

Open access
Irvin, Marguerite R., Booth, John N., Shimbo, Daichi, Lackland, Daniel T., Oparil, Suzanne, Howard, George, Safford, Monika M., Muntner, Paul +1 more·2014·Journal of the American Society of Hypertension

Abstract

Apparent treatment-resistant hypertension (aTRH) is defined as uncontrolled hypertension despite the use of three or more antihypertensive medication classes or controlled hypertension while treated with four or more antihypertensive medication classes. We evaluated the association of aTRH with incident stroke, coronary heart disease (CHD), and all-cause mortality. Participants from the population-based REasons for Geographic And Racial Differences in Stroke (REGARDS) Study treated for hypertension with aTRH (n = 2043) and without aTRH (n = 12,479) were included. aTRH was further categorized as controlled aTRH (≥4 medication classes and controlled hypertension) and uncontrolled aTRH (≥3 medication classes and uncontrolled hypertension). Over a median of 5.9, 4.4, and 6.0 years of follow-up, the multivariable adjusted hazard ratio for stroke, CHD, and all-cause mortality associated with aTRH versus no aTRH was 1.25 (0.94-1.65), 1.69 (1.27-2.24), and 1.29 (1.14-1.46), respectively. Compared with controlled aTRH, uncontrolled aTRH was associated with CHD (hazard ratio, 2.33; 95% confidence interval, 1.21-4.48), but not stroke or mortality. Comparing controlled aTRH with no aTRH, risk of stroke, CHD, and all-cause mortality was not elevated. aTRH was associated with an increased risk for coronary heart disease and all-cause mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jash.2014.03.003

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [21]Prineas R Crow R Zhang Z-M Minnesota code Manual of Electrocardiographich Findings 2 London Springer-Verlag 2010
  2. [34]Rothman KJ Greenland S Modern Epidemiology 2 Philadelphia Lippincott Williams & Wilkins 1998

Cited by

Sorted by citations

Authors
Irvin, M. R., Booth, J. N., Shimbo, D., Lackland, D. T., Oparil, S., Howard, G., Safford, M. M., Muntner, P., & Calhoun, D. A.
Affiliations
  • University of Alabama at Birmingham (US)
  • Columbia University Irving Medical Center (US)
  • Medical University of South Carolina (US)
Corresponding author
Irvin, Marguerite R.
Venue
Journal of the American Society of Hypertension
Publisher
Elsevier BV
Published
2014-06
Volume
8
Issue
6
Pages
405-413
ISSN
  • 1878-7436 (ISSN-L)
  • 1933-1711
OpenAlex
W2083024896
Cited by
146
References
40
Citations by year
2026: 9 · 2025: 9 · 2024: 12 · 2023: 8 · 2022: 10 · 2021: 10 · 2020: 16 · 2019: 16 · 2018: 10 · 2017: 14 · 2016: 16 · 2015: 14 · 2014: 1 · 2013: 1
FWCI
10.21
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Society of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Columbia Academic Commons (Columbia University)
Funders
  • National Institutes of Health (NS041588)
  • National Heart, Lung, and Blood Institute (R01HL080477)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079626)
  • National Institute of Neurological Disorders and Stroke (U01NS041588, NS 041588, R01NS041588)
  • National Institute on Minority Health and Health Disparities (P20MD006899)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
apparent treatment-resistant hypertension, uncontrolled hypertension, antihypertensive drugs, stroke, coronary artery disease, all-cause mortality, REGARDS study, cardiovascular risk
MeSH terms
Aged, Antihypertensive Agents, Blood Pressure, Cause of Death, Coronary Disease, Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged, Retrospective Studies, Risk Factors, United States, Incidence, Prevalence, Survival Rate, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review